These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20033474)

  • 41. Poly (DL-lactide-co-glycolide) (PLGA) nanoparticles with entrapped trans-cinnamaldehyde and eugenol for antimicrobial delivery applications.
    Gomes C; Moreira RG; Castell-Perez E
    J Food Sci; 2011 Mar; 76(2):N16-24. PubMed ID: 21535781
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
    Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
    J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preservation of lysozyme structure and function upon encapsulation and release from poly(lactic-co-glycolic) acid microspheres prepared by the water-in-oil-in-water method.
    Pérez C; De Jesús P; Griebenow K
    Int J Pharm; 2002 Nov; 248(1-2):193-206. PubMed ID: 12429473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of PLGA Variability in Controlled Drug Release from Dexamethasone Intravitreal Implants.
    Costello MA; Liu J; Kuehster L; Wang Y; Qin B; Xu X; Li Q; Smith WC; Lynd NA; Zhang F
    Mol Pharm; 2023 Dec; 20(12):6330-6344. PubMed ID: 37955890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interdependency of protein-release completeness and polymer degradation in PLGA-based implants.
    Ghalanbor Z; Körber M; Bodmeier R
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):624-30. PubMed ID: 23583495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Preparation and in-vitro degradation of polylactide and poly(L-lactide-co-glycolide)].
    Wei Z; Liu L; Zhang M; Yang F; Qi M
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):122-6. PubMed ID: 18435272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation, characterization and in vitro release study of BSA-loaded double-walled glucose-poly(lactide-co-glycolide) microspheres.
    Ansary RH; Rahman MM; Awang MB; Katas H; Hadi H; Mohamed F; Doolaanea AA; Kamaruzzaman YB
    Arch Pharm Res; 2016 Sep; 39(9):1242-56. PubMed ID: 26818028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential applications of PLGA film-implants in modulating in vitro drugs release.
    Dorta MJ; Santoveña A; Llabrés M; Fariña JB
    Int J Pharm; 2002 Nov; 248(1-2):149-56. PubMed ID: 12429469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and evaluation of raloxifene hydrochloride-loaded subdermal implants using hot-melt extrusion technology.
    Muhindo D; Ashour EA; Almutairi M; Repka MA
    Int J Pharm; 2022 Jun; 622():121834. PubMed ID: 35597391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug-Eluting Biodegradable Implants for the Sustained Release of
    Dharmayanti C; Gillam TA; Williams DB; Blencowe A
    Polymers (Basel); 2020 Dec; 12(12):. PubMed ID: 33297466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Release of gentamicin sulphate from biodegradable PLGA-implants produced by hot melt extrusion.
    Gosau M; Müller BW
    Pharmazie; 2010 Jul; 65(7):487-92. PubMed ID: 20662316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
    Wang N; Wu XS; Li JK
    Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
    Blanco D; Alonso MJ
    Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loading of plasmid DNA into PLGA microparticles using TROMS (Total Recirculation One-Machine System): evaluation of its integrity and controlled release properties.
    del Barrio GG; Novo FJ; Irache JM
    J Control Release; 2003 Jan; 86(1):123-30. PubMed ID: 12490378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of a novel multifunctional excipient poly(ethylene glycol)-block-oligo(vinyl sulfadimethoxine) in controlled release of lysozyme from PLGA microspheres.
    Taluja A; Bae YH
    Int J Pharm; 2008 Jun; 358(1-2):50-9. PubMed ID: 18395374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Co-effect of aqueous solubility of drugs and glycolide monomer on in vitro release rates from poly(D,L-lactide-co-glycolide) discs and polymer degradation.
    Kim JM; Seo KS; Jeong YK; Hai BL; Kim YS; Khang G
    J Biomater Sci Polym Ed; 2005; 16(8):991-1007. PubMed ID: 16128233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives.
    Yamaguchi Y; Takenaga M; Kitagawa A; Ogawa Y; Mizushima Y; Igarashi R
    J Control Release; 2002 Jun; 81(3):235-49. PubMed ID: 12044564
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique.
    Paillard-Giteau A; Tran VT; Thomas O; Garric X; Coudane J; Marchal S; Chourpa I; Benoît JP; Montero-Menei CN; Venier-Julienne MC
    Eur J Pharm Biopharm; 2010 Jun; 75(2):128-36. PubMed ID: 20226857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
    Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
    Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.